Announcing VanEck Vectors Equity ETFs’ September 2018 Distributions
September 28 2018 - 6:03PM
Business Wire
VanEck announced today its regular distributions per share for
the VanEck Vectors® equity exchange-traded funds.
Ex-Date
Record
Date
Payable
Date
October 1, 2018 October 2, 2018 October 5, 2018
Expected Distribution Distribution Amount Fund
Ticker Frequency
Per Share VanEck Vectors Pharmaceutical ETF
PPH
Quarterly $ 0.2345
The majority, and possibly all, of the dividend distributions
will be paid out of net investment income earned by the Funds. A
portion of these distributions may come from net short-term or
long-term realized capital gains or return of capital.
The final tax treatment of these dividends will be reported to
shareholders on their 1099-DIV form, which is mailed after the
close of each fiscal year. The amount of dividends paid by each ETF
may vary from time to time. Past amounts of dividends are no
guarantee of future dividend payment amounts.
IRS Circular 230 disclosure: VanEck does not provide legal, tax
or accounting advice. Any statement contained in this communication
concerning U.S. tax matters is not intended or written to be used,
and cannot be used, for the purpose of avoiding penalties imposed
on the relevant taxpayer. Shareholders or potential shareholders of
the VanEck Vectors ETFs should obtain their own independent tax
advice based on their particular circumstances.
If you have any questions concerning this information or the
VanEck Vectors ETFs in general, please call 800.826.2333 between
9:00 a.m. and 5:30 p.m., Monday through Friday.
About VanEck
VanEck has a history of looking beyond the financial markets to
identify trends that are likely to create impactful investment
opportunities. We were one of the first U.S. asset managers to
offer investors access to international markets. This set the tone
for the firm’s drive to identify asset classes and trends –
including gold investing in 1968, emerging markets in 1993, and
exchange-traded funds in 2006 – that subsequently shaped the
investment management industry.
Today, VanEck offers active and passive strategies with
compelling exposures supported by well-designed investment
processes. As of August 31, 2018, VanEck managed approximately
$45.8 billion in assets, including mutual funds, ETFs, and
institutional accounts. The firm’s capabilities range from core
investment opportunities to more specialized exposures to enhance
portfolio diversification. Our actively managed strategies are
fueled by in-depth, bottom-up research and security selection from
portfolio managers with direct experience in the sectors and
regions in which they invest. Investability, liquidity, diversity,
and transparency are key to the experienced decision-making around
market and index selection underlying VanEck’s passive
strategies.
Since our founding in 1955, putting our clients’ interests
first, in all market environments, has been at the heart of the
firm’s mission.
Please call 800.826.2333 or visit vaneck.com for the most recent
month-end performance of VanEck Vectors ETFs. This information will
be available no later than seven business days after the most
recent month end.
The principal risks of investing in VanEck Vectors ETFs include
sector, market, economic, political, foreign currency, world event,
index tracking and non-diversification risks, as well as
fluctuations in net asset value and the risks associated with
investing in less developed capital markets. The assets of some
Funds may be concentrated in a particular sector and may be subject
to more risk than investments in a diverse group of sectors. The
Funds may loan their securities, which may subject them to
additional credit and counterparty risk.
Fixed income investments are subject to interest rate risk,
credit risk, the risk that the issuer of a bond will fail to pay
interest and principal in a timely manner, or that negative
perceptions of the issuer’s ability to make such payments will
cause the price of that bond to decline. Bonds and bond funds
will decrease in value as interest rates rise. In addition when
interest rates fall income may decline. Please see the
Prospectus and Summary Prospectus of each Fund for more complete
information regarding its specific risks.
The net asset value (NAV) of an ETF is determined at the close
of each business day, and represents the dollar value of one share
of the ETF; it is calculated by taking the total assets of an ETF
subtracting total liabilities, and dividing by the total number of
shares outstanding. The NAV is not necessarily the same as an ETF's
intraday trading value. Investors should not expect to buy or sell
shares at NAV. Total returns are based upon closing “market price”
(price) of the ETF on the dates listed.
Fund shares are not individually redeemable and will be issued
and redeemed at their NAV only through certain authorized
broker-dealers in large, specified blocks of shares called
“creation units” and otherwise can be bought and sold only through
exchange trading. Shares may trade at a premium or discount to
their NAV in the secondary market. You will incur brokerage
expenses when trading Fund shares in the secondary market.
Investors may call 800.826.2333 or visit
vaneck.com for a free prospectus and
summary prospectus. Investing involves risk,
including possible loss of principal. Bonds and bond funds will
decrease in value as interest rates rise. An investor should
consider the investment objective, risks, and charges and expenses
of VanEck Vectors ETFs carefully before investing. The prospectus
and summary prospectus contains this and other information. Please
read the prospectus and summary prospectus carefully before
investing.
Van Eck Securities Corporation, Distributor,
666 Third Avenue, New York, NY 10017
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180928005663/en/
MacMillan CommunicationsMike MacMillan/Chris Sullivan,
212-473-4442chris@macmillancom.com
Peregrine Pharmaceuticals Inc. (MM) (NASDAQ:PPHMD)
Historical Stock Chart
From Dec 2024 to Jan 2025
Peregrine Pharmaceuticals Inc. (MM) (NASDAQ:PPHMD)
Historical Stock Chart
From Jan 2024 to Jan 2025